July 11, 2026
The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis the-silent-pandemic-global-progress-and-persistent-gaps-in-the-fight-against-viral-hepatitis

The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis

Ali Ikhwan May 8, 2026 0
By Global Health Correspondent Despite significant strides in medical innovation and public health policy, viral hepatitis remains...
Read More Read more about The Silent Pandemic: Global Progress and Persistent Gaps in the Fight Against Viral Hepatitis
Strengthening the Frontline: $200,000 Inaugural Award Marks New Era for Canadian Breast Surgical Oncology Research strengthening-the-frontline-200000-inaugural-award-marks-new-era-for-canadian-breast-surgical-oncology-research

Strengthening the Frontline: $200,000 Inaugural Award Marks New Era for Canadian Breast Surgical Oncology Research

Reynand Wu May 8, 2026 0
In a landmark move for the Canadian medical community, Breast Cancer Canada (BCC) and the Canadian Society...
Read More Read more about Strengthening the Frontline: $200,000 Inaugural Award Marks New Era for Canadian Breast Surgical Oncology Research
Unmasking the Molecular Dance: New Imaging Technique Reveals the Secrets of Cancer-Driving Receptors unmasking-the-molecular-dance-new-imaging-technique-reveals-the-secrets-of-cancer-driving-receptors

Unmasking the Molecular Dance: New Imaging Technique Reveals the Secrets of Cancer-Driving Receptors

Evan Lee Salim May 8, 2026 0
Introduction: A New Window into Cellular Chaos In the high-stakes world of oncology, few protein families are...
Read More Read more about Unmasking the Molecular Dance: New Imaging Technique Reveals the Secrets of Cancer-Driving Receptors
Entrada Therapeutics’ DMD Drug Falls Short of Investor Expectations, Stock Plummets Amidst Competitive Landscape entrada-therapeutics-dmd-drug-falls-short-of-investor-expectations-stock-plummets-amidst-competitive-landscape

Entrada Therapeutics’ DMD Drug Falls Short of Investor Expectations, Stock Plummets Amidst Competitive Landscape

Evan Lee Salim May 8, 2026 0
San Diego, CA – May 15, 2024 – Entrada Therapeutics, a biotechnology company focused on developing novel...
Read More Read more about Entrada Therapeutics’ DMD Drug Falls Short of Investor Expectations, Stock Plummets Amidst Competitive Landscape

You may have missed

decades-old-protein-new-cancer-foe-unveiling-erythropoietins-surprising-role-in-immune-evasion

Decades-Old Protein, New Cancer Foe: Unveiling Erythropoietin’s Surprising Role in Immune Evasion

Reynand Wu July 11, 2026
the-global-blood-divide-who-report-exposes-critical-gaps-in-life-saving-transfusion-access

The Global Blood Divide: WHO Report Exposes Critical Gaps in Life-Saving Transfusion Access

Iffa Jayyana July 11, 2026
beyond-the-diagnosis-bionews-launches-the-rare-journey-to-humanize-the-rare-disease-experience

Beyond the Diagnosis: Bionews Launches "The Rare Journey" to Humanize the Rare Disease Experience

Nana July 11, 2026
the-future-of-precision-oncology-mercks-calderasib-and-the-pivot-to-combinability

The Future of Precision Oncology: Merck’s Calderasib and the Pivot to Combinability

Asro July 11, 2026